<DOC>
	<DOCNO>NCT01516320</DOCNO>
	<brief_summary>The objective study investigate different mechanism Gastric Bypass ( GBP ) , laparoscopic adjustable gastric banding ( LAGB ) vertical sleeve gastrectomy ( VSG ) affect glucose control . We wish understand role weight loss versus change gut peptide short long term morbidly obese patient Type 2 Diabetes Mellitus GBP , LAGB VSG . The 2 surgical group compare 10 % equivalent weight loss surgery term gut hormone level , insulin secretion glucose control .</brief_summary>
	<brief_title>Mechanisms Diabetes Relapse After Bariatric Surgery</brief_title>
	<detailed_description>The mechanism type 2 diabetes ( T2DM ) remission gastric bypass surgery ( GBP ) unclear . The level gut hormone incretins effect insulin secretion , impaired T2DM , markedly increase GBP . The anatomical change GBP , rather weight loss , seem responsible change incretins . The objective proposal investigate different mechanism GBP , laparoscopic adjustable gastric banding ( LAGB ) vertical sleeve gastrectomy ( VSG ) affect glucose control . We wish understand role weight loss versus change gut peptide short long term morbidly patient T2DM GBP , LAGB VSG . AIM 1 : Will study short term change incretins level effect obese individual T2DM GBP , LAGB VSG , 1 month GBP equivalent weight loss LAGB VSG . AIM 2 : Will study long-term ( 12 24 month surgery ) change incretin effect insulin secretion , patient T2DM GBP , LAGB VSG . AIM 3 : Will study change insulin secretion IV glucose ( AIRg ) insulin sensitivity ( Si ) , measure minimal model , patient T2DM GBP , VSG LAGB , 24 month surgery , weight stability condition control diet .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Post GBP , LAGB VSG Subjects Must able attend 4 study visit St. Luke 's Roosevelt Hospital Center Manhattan , New York City History Type 2 Diabetes surgery 35 &lt; BMI &lt; 50 NonSmoker Total Body Weight &lt; 300 LBS 30 &lt; Age &lt; 60 HbA1c &lt; 9 % Resting Blood Pressure &lt; 160/100 mmHg Beta Blockers discontinue 2 week prior Fasting Triglyceride Concentration &lt; 600 mg/dl ( patient dyslipidemia medication ) Without recent ( within last 6 month ) CHD history ( prior history angioplasty coronary artery bypass surgery normal stress test ok ) 1 . Patients abnormal thyroid , renal function , know malabsorption syndrome seizure disorder require anti epileptic therapy , and/or elevation liver enzymes three time normal limit . 2 . Patients significant secondary complication diabetes would preclude undergoing gastric bypass surgery . This would include significant psychiatric , renal neurological , know active coronary artery disease . 3 . Any abnormality maximum exercise stress test indicate would unsafe undergo bariatric surgery . 4 . Currently pregnant nursing . 5 . Known cardiovascular disease 6 . Patient current mucosal ( gastrointestinal , respiratory , urogenital ) skin ( cellulitis ) infection 7 . HbA1c &gt; 9 % diabetes diagnose 6 year prior enrollment , patient take insulin TZD ( Avandia , Actos , Exenatide , DPPIV inhibitor etc . ) time enrollment . 8 . Patients diagnose intestinal condition chronic diarrhea , diverticulitis , irritable bowel syndrome . These clinical condition would interfere collection interpretation H2 breath test . 9 . Any condition , opinion investigator , may make candidate unsuitable participation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Gastric Bypass</keyword>
	<keyword>Laparoscopic Banding</keyword>
	<keyword>Vertical Sleeve Gastrectomy</keyword>
</DOC>